REG - AIM - AIM Notice - 30/10/2025

One HealthAnnouncement

Yesterday 09:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251030:nRSd3799Fa&default-theme=true

RNS Number : 3799F  AIM  30 October 2025

NOTICE

 

30/10/2025 - 08:00

 

The London Stock Exchange admits the following securities to trading on AIM:

 

 Allergy Therapeutics Plc
 1,375,000,000  ORDINARY SHARES OF 0.1P EACH, FULLY PAID  (B02LCQ0)(GB00B02LCQ05)

 

 Bezant Resources Plc
 72,000,000  ORDINARY SHARES OF 0.002P EACH, FULLY PAID  (B1CKQD9)(GB00B1CKQD97)

 

 GENEDRIVE PLC
 4,708,584  ORDINARY SHARES OF 0.015P EACH, FULLY PAID  (B1VKB24)(GB00B1VKB244)

 

 Landore Resources Limited
 35,515,151  ORDINARY SHARES OF NO PAR VALUE, FULLY PAID  (BMX4VR6)(GG00BMX4VR69)

 

 Metals Exploration Plc
 173,681  ORDINARY SHARES OF GBP0.0001 EACH  (B0394F6)(GB00B0394F60)

 

 Newmark Security Plc
 20,000  ORDINARY SHARES OF GBP0.05 EACH, FULLY PAID  (BNYM9W7)(GB00BNYM9W73)

 

 One Health Group plc
 21,885  ORDINARY SHARES OF 0.5P EACH, FULLY PAID  (BNNT059)(GB00BNNT0595)

 

 Touchstone Exploration Inc
 63,636,363  COMMON SHARES OF NO PAR VALUE FULLY PAID (DI)  (BD8ZCD4)(CA89156L1085)

 

 Vast Resources Plc
 529,027,778  ORDINARY SHARES OF 0.1P EACH, FULLY PAID  (BQ7WTT2)(GB00BQ7WTT20)

 

If you have any queries or require further information, please contact Market
Operations on 020 7797 4310.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  AMOBLBDGCDDDGUC



            Copyright 2019 Regulatory News Service, all rights reserved